These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26242248)

  • 21. Benzimidazole inhibitors of the major cysteine protease of
    Pereira GA; Santos LH; Wang SC; Martins LC; Villela FS; Liao W; Dessoy MA; Dias LC; Andricopulo AD; Costa MA; Nagem RA; Caffrey CR; Liedl KR; Caffarena ER; Ferreira RS
    Future Med Chem; 2019 Jul; 11(13):1537-1551. PubMed ID: 31469332
    [No Abstract]   [Full Text] [Related]  

  • 22. Antitrypanosomal structure-activity-relationship study of synthetic cynaropicrin derivatives.
    Usuki T; Sato M; Hara S; Yoshimoto Y; Kondo R; Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M
    Bioorg Med Chem Lett; 2014 Feb; 24(3):794-8. PubMed ID: 24433861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitrypanosomal compounds from the essential oil and extracts of Keetia leucantha leaves with inhibitor activity on Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase.
    Bero J; Beaufay C; Hannaert V; Hérent MF; Michels PA; Quetin-Leclercq J
    Phytomedicine; 2013 Feb; 20(3-4):270-4. PubMed ID: 23312849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and antiparasitic activity of AZ960 as a Trypanosoma brucei ERK8 inhibitor.
    Valenciano AL; Ramsey AC; Santos WL; Mackey ZB
    Bioorg Med Chem; 2016 Oct; 24(19):4647-4651. PubMed ID: 27519462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trypanocidal and cysteine protease inhibitory activity of isopentyl caffeate is not linked in Trypanosoma brucei.
    Steverding D; da Nóbrega FR; Rushworth SA; de Sousa DP
    Parasitol Res; 2016 Nov; 115(11):4397-4403. PubMed ID: 27535679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary Structure-Activity Relationship Study of the MMV Pathogen Box Compound MMV675968 (2,4-Diaminoquinazoline) Unveils Novel Inhibitors of
    Dize D; Tata RB; Keumoe R; Kouipou Toghueo RM; Tchatat MB; Njanpa CN; Tchuenguia VC; Yamthe LT; Fokou PVT; Laleu B; Duffy J; Bishop OT; Boyom FF
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenolic Constituents of Medicinal Plants with Activity against Trypanosoma brucei.
    Sun YN; No JH; Lee GY; Li W; Yang SY; Yang G; Schmidt TJ; Kang JS; Kim YH
    Molecules; 2016 Apr; 21(4):480. PubMed ID: 27077842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-guided development of selective TbcatB inhibitors.
    Mallari JP; Shelat AA; Kosinski A; Caffrey CR; Connelly M; Zhu F; McKerrow JH; Guy RK
    J Med Chem; 2009 Oct; 52(20):6489-93. PubMed ID: 19769357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the Antiplasmodial 2-Aminopyridines as Potential Antitrypanosomal Agents.
    Veale CGL; Laming D; Swart T; Chibale K; Hoppe HC
    ChemMedChem; 2019 Dec; 14(24):2034-2041. PubMed ID: 31670464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaign.
    Diaz R; Luengo-Arratta SA; Seixas JD; Amata E; Devine W; Cordon-Obras C; Rojas-Barros DI; Jimenez E; Ortega F; Crouch S; Colmenarejo G; Fiandor JM; Martin JJ; Berlanga M; Gonzalez S; Manzano P; Navarro M; Pollastri MP
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3253. PubMed ID: 25340575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.
    Hiltensperger G; Jones NG; Niedermeier S; Stich A; Kaiser M; Jung J; Puhl S; Damme A; Braunschweig H; Meinel L; Engstler M; Holzgrabe U
    J Med Chem; 2012 Mar; 55(6):2538-48. PubMed ID: 22376072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicinal Chemistry Optimization of a Diaminopurine Chemotype: Toward a Lead for
    Singh B; Diaz-Gonzalez R; Ceballos-Perez G; Rojas-Barros DI; Gunaganti N; Gillingwater K; Martinez-Martinez MS; Manzano P; Navarro M; Pollastri MP
    J Med Chem; 2020 Sep; 63(17):9912-9927. PubMed ID: 32786222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds.
    Venkatraj M; Ariën KK; Heeres J; Joossens J; Dirié B; Lyssens S; Michiels J; Cos P; Lewi PJ; Vanham G; Maes L; Van der Veken P; Augustyns K
    Bioorg Med Chem; 2014 Oct; 22(19):5241-8. PubMed ID: 25199582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis.
    Previti S; Ettari R; Di Chio C; Ravichandran R; Bogacz M; Hellmich UA; Schirmeister T; Cosconati S; Zappalà M
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of dipeptide nitriles as inhibitors of rhodesain, a major cysteine protease of Trypanosoma brucei.
    Schirmeister T; Schmitz J; Jung S; Schmenger T; Krauth-Siegel RL; Gütschow M
    Bioorg Med Chem Lett; 2017 Jan; 27(1):45-50. PubMed ID: 27890381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New peptidomimetic rhodesain inhibitors with improved selectivity towards human cathepsins.
    Jung S; Fuchs N; Grathwol C; Hellmich UA; Wagner A; Diehl E; Willmes T; Sotriffer C; Schirmeister T
    Eur J Med Chem; 2022 Aug; 238():114460. PubMed ID: 35597010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and structure-activity relationship of Trypanosoma brucei leucyl-tRNA synthetase inhibitors as antitrypanosomal agents.
    Ding D; Meng Q; Gao G; Zhao Y; Wang Q; Nare B; Jacobs R; Rock F; Alley MR; Plattner JJ; Chen G; Li D; Zhou H
    J Med Chem; 2011 Mar; 54(5):1276-87. PubMed ID: 21322634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cathepsin-L can resist lysis by human serum in Trypanosoma brucei brucei.
    Alsford S; Currier RB; Guerra-Assunção JA; Clark TG; Horn D
    PLoS Pathog; 2014 May; 10(5):e1004130. PubMed ID: 24830321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of the electrophile of chloronitrobenzamide leads active against Trypanosoma brucei.
    Hwang JY; Smithson DC; Holbrook G; Zhu F; Connelly MC; Kaiser M; Brun R; Kiplin Guy R
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4127-31. PubMed ID: 23746473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.